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Medical Centre, Petach Tikva and 4) Nuclear Medicine Department, Rabin Medical Centre, Petach Tikva, IsraelAbstractThe exact incidence of extra-cardiac complications (ECC) in patients with infective endocarditis (IE) is unknown but presumed to be high.
These patients, although mostly asymptomatic, may require a more aggressive therapeutic approach. 18ﬂuorodeoxyglucose–positron
emission tomography/computed tomography (FDG-PET/CT) is used for the diagnosis of infections, but its role in the early diagnosis of IE
complications is still unclear. This study aimed to evaluate the role of FDG-PET/CT in the early diagnosis of ECC in IE and its
implications for medical management. We prospectively studied 40 consecutive patients with a conﬁrmed diagnosis of IE (according to
the modiﬁed Duke criteria) who underwent a whole body FDG-PET/CT study within 14 days from diagnosis. The FDG-PET/CT
demonstrated ECC in 17 (42.5%) patients, while 8 (38.1%) of them were asymptomatic. The most frequent embolic sites were
musculoskeletal and splenic. Owing to the FDG-PET/CT ﬁndings, treatment planning was modiﬁed in 14 (35%) patients. This included
antibiotic treatment prolongation (27.5%), referral to surgical procedures (15%) and, most substantially, prevention of unnecessary device
extraction (17.7%). According to our experiences, FDG-PET/CT imaging was useful in the detection of embolic and metastatic infections
in IE. This clinical information had a signiﬁcant diagnostic and therapeutic impact in managing IE disease.
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5These authors contributed equally to this workBackgroundThe exact incidence of extra-cardiac complications (ECC; e.g.
embolic events andmetastatic infections) in infective endocarditis
(IE) remains unknown, but is considered to be high and reported
in 20–50% of patients in various reports [1–3]. Moreover, a
substantial percentage of patients remain relatively asymptomatic
[4] and present a diagnostic challenge for physicians. BecauseClinical Microbiology and Infection © 2014 European Society of Cthese patients may also require a different therapeutic approach,
prompt diagnosis of embolic complications is essential.
Different imaging modalities have been used for the diagnosis
of ECC of IE (e.g. X-rays, ultrasonographic imaging, nuclear
scintigraphy, computerized tomography and magnetic reso-
nance imaging). Each imaging modality has its own niche in the
detection spectrum of different complications, but none with
the ability to provide a comprehensive diagnostic evaluation [5].
In recent years, 18ﬂuorodeoxyglucose–positron emission to-
mography/computed tomography (FDG-PET/CT) has emerged
as an efﬁcient modality for the identiﬁcation of neoplastic, in-
ﬂammatory and infectious processes [6,7]. Several studies have
demonstrated the role of FDG-PET/CT in detecting infections
of vascular prostheses [8–10] and implantable pacemakers/
deﬁbrillators [11–14]. Furthermore, an important role of FDG-Clin Microbiol Infect 2015; 21: 69–76
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.cmi.2014.08.012
70 Clinical Microbiology and Infection, Volume 21 Number 1, January 2015 CMIPET/CT in the diagnosis of IE has been proposed by several
recent publications [15–21]. Few data regarding the diagnosis
of ECC by FDG-PET/CT exist [22–24]. Therefore, we aimed to
assess the role of FDG-PET/CT in diagnosing ECC of IE.MethodsStudy population
All consecutive patients (> 18 years old) with a deﬁnite diag-
nosis of IE admitted to our medical centre between May 2010
and July 2013, were included in the study. The deﬁnite diagnosis
of IE was conﬁrmed using the modiﬁed Duke criteria [25]. We
excluded clinically unstable patients, patients who required
emergency cardiac surgery, patients who were unable to
remain in a prone position and patients who were unable or
unwilling to provide an inform consent. The study protocol was
approved by the institutional review board.
The following data were collected on admission and during
the hospitalization for all patients: demographic baseline char-
acteristics, co-morbidities, Charlson co-morbidity index [26],
physical examination report, trans-oesophageal echocardio-
graphic (TEE) evaluation, microbiological and laboratory data
including serum markers of inﬂammation (C-reactive protein,
rheumatic factor and white blood cell count), course of hos-
pitalization, FDG-PET/CT results and clinical outcomes.
All patients underwent FDG-PET/CT within 14 days from the
established diagnosis. Inevitably, all examinations were per-
formed during antibiotic treatment, which was initiated by the
treating physicians who were unrelated to the study staff. Nine
patients had urgent surgical valve replacement. In six patients the
valve replacement was performed before FDG-PET/CT.
All further evaluation, antibiotic treatment type and dura-
tion, and reference to surgical procedures were at the discre-
tion of the treating physician, not involved in the study.
Additional imaging modalities (e.g. chest X-ray, ultrasound, CT
or bone scintigraphy) were performed if indicated and at the
discretion of the treating physician.
The FDG-PET/CT ﬁndings were categorized into ECC
(embolic and distant infection), concomitant infections, poten-
tial port of entry and incidental ﬁndings. The diagnosis of
embolic and distant infections included the following ﬁndings:
septic infarction and/or metastatic abscess to spleen, brain,
kidneys, liver, peripheral vasculature and lung, septic arthritis
and spondylodiscitis. Furthermore, we evaluated the impact of
FDG-PET/CT ﬁndings on the management and clinical outcome
according to three categories: effect on antibiotic duration
(prolonged or shortened), referral for surgical procedure
(excision of infection site, extraction of infected foreign body)
or prevention of unnecessary surgical procedures.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectDue to the small sample of patients, only descriptive statis-
tics were used to present the results of the study.
Whole body FDG PET/CT
All patients underwent FDG-PET/CT on a GE Discovery STE
Whole Body PET CT scanner (GE Medical Systems, Milwaukee,
WI, USA) after 4 h of fasting. Blood glucose levels were examined
before 18F-FDG injection to ensure a blood glucose level <
200 mg/dl. CT images were acquired at 120 kV and 80 mA, pitch
1.75, 0.8 s per tube rotation and slice thickness of 3.75 mm.
During whole body CT examination, 80 mL of contrast agent
(Ultravist 300, Schering AG, Berlin, Germany) was administered
intravenously to ensure fully diagnostic CT data (19 patients with
renal failure or iodine allergy underwent CT without contrast
intravenous administration). The PET scan was performed
45–90 minutes after intravenous injection of 10–15 mCi of 18F-
FDG. The contrast-enhanced CT was used for attenuation
correction of the PET data. PET was performed from head to
mid-thigh, 2–3min per bed position. Resulting in a total PET scan
time of approximately 20–25 min (seven or eight bed positions).
Splenic hyperactivity due to infection/haematopoietic reac-
tion was recognized by diffuse increased uptake of FDG in the
spleen. Infarct or abscess was recognized by either focal
increased or decreased uptake of FDG in the spleen. The latter
was considered to be ECC embolic/metastatic to the spleen. An
ECC brain ﬁnding was considered when either increased or
decreased focal uptake was demonstrated compared with the
normal brain uptake: increased around abscess and decreased
in stroke area.
The images were interpreted by two nuclear medicine and
radiology experts who were blinded to the patients’ other
imaging results.ResultsWe included 40 patients (mean age 58.9 ± 15.8 years, 28 male)
with a deﬁnite diagnosis of IE who underwent FDG-PET/CT.
Baseline demographic characteristics are summarized in
Table 1. Eight patients (20%) had prosthetic valve endocarditis
(four aortic valve and four mitral valve). Additional predisposing
factors for IE included endovascular devices such as implantable
pacemakers or deﬁbrillators, left ventricular assist device
(LVAD) and arterial lines in 14 patients (35%) (Table 1).
The diagnosis of deﬁnite IE was established in 27 patients
using two major criteria and in 13 patients using one major and
three minor criteria. Eight patients had culture negative endo-
carditis: two had positive serology for Q-fever and one for
Bartonella. The other ﬁve were probably negative because of
previous antibiotic treatment. The blood cultures and otherious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 69–76
TABLE 1. Population study baseline characteristics
Characteristics Total (%) n [ 40
Baseline characteristics
Age (years) 58.9 ± 15.8
Gender, men 28 (70)
Diabetes mellitus 12 (40)
Hypertension 18 (45)
Ischaemic heart disease 9 (22.5)
Chronic renal failure 9 (22.5)
Haemodialysis 3 (7.5)
Prior stroke 3 (7.5)
History of cancer 6 (15)
Charlson Score 3.7 ± 2.6
Predisposing factors to infective endocarditis
Prior infective endocarditis 6 (15)
Prosthetic valve/Valve repair 13 (40.6)
Congenital heart disease 2 (5)
Endovascular devices
Aortic graft/Stent 4 (10)
Implantable device (pacemaker/ICD/CRT) 10 (25)
Left ventricular assist device 1 (2.5)
Arterial line (permacath, portacath) 3 (7.5)
Drug abuser 1 (2.5)
Invasive procedure before admission 9 (22.5)
Abbreviations: CRT, cardiac resynchronization therapy; ICD, implantable
cardioverter deﬁbrillator.
CMI Orvin et al. FDG-PET/CT in detection of ECC 71laboratory characteristics are summarized in Table 2. A path-
ological conformation for IE was obtained in nine patients who
underwent urgent surgical valve replacement.
All patients underwent transthoracic echocardiography
(TTE) as well as TEE in their initial evaluation (Table 2). A clear
vegetation (mean size 9.8 ± 6.7 mm) was demonstrated by TEE
in 26 (65%) patients (eight prosthetic valves, 15 native valves
and three implantable device electrodes). Two patients were
diagnosed with perivalvular abscess and four (10%) had a new
valvular insufﬁciency. The remaining eight (20%) patients had no
evidence for IE by echocardiography (TEE) imaging.TABLE 2. Blood cultures, laboratory data and
echocardiographic ﬁndings
Laboratory data Total (%) n [ 40
Bacterial pathogens
Streptococcus viridans 4 (10)
Staphylococcus aureus 8 (20)
Streptococcus spp. 6 (15)
Enterococcus faecalis 5 (12.5)
HACEK 2 (5)
Coxiella burnetii 2 (5)
Listeria spp. 1 (2.5)
Bartonella spp. 1 (2.5)
CoNS 4 (10)
Propionibacterium acnes 1 (2.5)
Diphtheroids spp. 1 (2.5)
Echocardiographic ﬁndings-
Vegetation on prosthetic valve 8 (20)
Vegetation on native valve 15 (37.5)
Perivalvular abscess 2 (5)
New valvular insufﬁciency 8 (20)
Vegetation on electrode 3 (7.5)
No ﬁndings 4 (10)
Vegetation size (mm) 9.8 ± 6.7
Laboratory results –
White blood cell count (K/μL) 13.3 ± 8.7
Serum creatinine (mg/dL) 1.4 ± 1.0
Serum C-reactive protein (mg/dL) 13.7 ± 8.6
Abbreviations: CoNS, coagulase-negative staphylococcus; HACEK, Haemophilus
species (Haemophilus parainﬂuenzae, Haemophilus aphrophilus, Haemophilus
paraphrophilus), Actinobacillus actinomycetemcomitans, Cardiobacterium hominis,
Eikenella corrodens, and Kingella species.
Clinical Microbiology and Infection © 2014 European Society of Clinical MicrobioloAll patients underwent whole body FDG-PET/CT shortly af-
ter the diagnosis of deﬁnite IE was established with a median time
of 5 days from diagnosis (range 1–14 days) and amedian duration
of 7 days from antibiotic treatment initiation (range 2–20 days).
Extra-cardiac FDG-PET/CT ﬁndings
Thirty out of 40 (75%) patients had relevant extra-cardiac
ﬁndings on FDG-PET/CT examination. Embolic/metastatic
ECC was evident in 17 patients (42.5%), with musculoskeletal
and splenic being the most frequent embolic sites (Table 3).
Eight of these patients (38.1%) were asymptomatic at the time
of diagnosis. Examples for images of metastatic infections are
shown in Figs. 1 and 2. A concomitant infection was demon-
strated in 12 (30%) patients (Table 3). A possible portal of entry
for infection was detected in four (10%) patients. Non-
infectious (incidental) ﬁndings were demonstrated in six
(15%) patients. In two patients a colonic polyp/mass was
demonstrated with PET/CT and diagnosed as malignant ade-
noma with colonoscopy in both cases (Fig. 3a,b).
Cardiac ﬁndings
Six patients underwent imaging following urgent valve
replacement, so we evaluated only 34 patients for the evidence
of valvular IE by FDG-PET/CT. Positive FDG intake was
demonstrated in only two (5.9%) patients, both with prosthetic
valves. The two cases of perivalvular abscess that were diag-
nosed in TEE were not demonstrated by FDG-PET/CT. In
addition, a positive FDG intake was well demonstrated on one
of three infected pacemaker electrodes and in three infected
aortic grafts/stents (Table 3).TABLE 3. Study cohort 18ﬂuorodeoxyglucose–positron
emission tomography/computed tomography (FDG-PET/CT)
ﬁndings
FDG-PET/CT ﬁndings Total (%) n [ 40
Extra-cardiac






Concomitant infections 12 (30)
Pneumonia 10
Osteomyelitis of the foot 1
Sternitis 1
Non-infectious ﬁndings 6 (15)
Colon mass/polyp 3
Thyroid gland nodule 2
Lung nodules 1
Possible portal of entry 4 (10)
New implanted epicardial lead 1





Implantable device electrode 1/40 (2.5)
Ascending aorta graft/stent 3/40 (7.5)
Numbers are for PET ﬁndings (a patient may have had more than one ﬁnding).
gy and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 69–76
FIG. 1. Example of positive 18ﬂuorodeoxyglucose–positron emission tomography/computed tomography (FDG-PET/CT) for extra-cardiac metastatic
infection in a 66-year-old women with Staphylococcus aureus infective endocarditis demonstrates a psoas muscle (left) and paraspinal abscess. The FDG-
PET/CT images are presented as sagittal and cranial sections in CT, fused and attenuation-corrected maximal intensity projection images.
FIG. 2. Example of positive 18ﬂuorodeoxyglucose–positron emission tomography/computed tomography (FDG-PET/CT) for extra-cardiac metastatic
infection in a 44-year-old drug abuser with right-sided infective endocarditis demonstrates bilateral lung cavitary infections. The FDG-PET/CT images
are presented as cranial sections in CT, fused and attenuation-corrected maximal intensity projection images.
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FIG. 3. Example of positive 18ﬂuorodeoxyglucose–positron emission tomography/computed tomography (FDG-PET/CT) for extra-cardiac ﬁnding in a
60-year-old man with left ventricular assist device and Streptococcus bovis infective endocarditis. The FDG-PET/CT shows an abnormal uptake in the
right colon (arrow), revealing a neoplasm that was conﬁrmed as villous adenoma by colonoscopy and no uptake around the device. This ﬁnding was
presumed to be the port of entry for the bacteraemia. The FDG-PET/CT images are presented as cranial (a) and sagittal (b) sections and in CT, fused
and attenuation-corrected maximal intensity projection images.
CMI Orvin et al. FDG-PET/CT in detection of ECC 73Clinical outcome and FDG-PET/CT impact on
management
During hospitalization, nine (22.5%) patients required urgent
valve replacement and ten (25%) patients required surgical
excision of infected locus or infected foreign body. The mean
antibiotic treatment duration (excluding Q fever IE) was
6.1 ± 2.1 weeks. The treatment plan was signiﬁcantly altered in
14 out of 40 (35%) patients owing to the FDG-PET/CT ﬁndings.
Antibiotic treatment was prolonged in 11 (27.5%) patients as
the result of detection of embolic infections by the FDG-PET/
CT. Six (15%) patients were referred to surgical procedures
(excision of infected locus or infected device) as the result of
FDG-PET/CT ﬁndings. Additionally, unnecessary deviceClinical Microbiology and Infection © 2014 European Society of Clinical Microbioloextraction was avoided in three patients (two patients with
implantable device and one patient with LVAD) owing to the
FDG-PET/CT results with an excellent clinical outcome and no
recurrence of documented infection or requirement for device
removal at a later time.DiscussionOur study demonstrated several important ﬁndings regarding
the use of FDG-PET/CT imaging in patients with deﬁnite IE:
primarily, relevant extra-cardiac ﬁndings on FDG-PET/CT were
demonstrated in the majority of patients (75%). Thegy and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 69–76
74 Clinical Microbiology and Infection, Volume 21 Number 1, January 2015 CMIinformation obtained by a single FDG-PET/CT examination was
useful for the diagnosis of ECC, determination of the source of
infections and concomitant infections leading to important
changes in the course of the treatment strategy. Given the
interpretation of FDG-PET/CT, signiﬁcant therapeutic changes
were made in more than one-third of our patients. However,
the role of FDG-PET/CT in the demonstration of cardiac le-
sions was very limited and much inferior to TEE.
Early diagnosis of ECC has important therapeutic implica-
tions [27–29] but may be extremely challenging because of the
lack of characteristic symptoms and the need for several im-
aging modalities to perform a comprehensive evaluation [5]. In
our study, we have demonstrated a rate of over 40% of ECC in
patients who were already managed with antibiotic treatment.
These ﬁndings, which have signiﬁcant implications for clinical
management, may have been overlooked through the lack of
extra-cardiac symptoms. Currently, there are no speciﬁc rec-
ommendations for routine ECC evaluation and different mo-
dalities are being used according to speciﬁc symptoms. By
performing a whole body FDG-PET/CT, we completed a rapid
comprehensive evaluation using a single diagnostic modality.
Taking into account bureaucratic and technical factors we es-
timate that the time required to perform the necessary evalu-
ation using several different modalities to obtain the same
diagnostic ﬁndings as FDG-PET/CT would be an average of 7–8
days as opposed to 2–3 days, respectively.
Nowadays, the evaluation of IE has become even more
challenging as the result of the extensive use of emerging new
intravascular and intra-cardiac devices. Permanent implants
provide a continued source of bacteraemia but may impair
diagnosis with echocardiography through the appearance of
mechanical artefacts. FDG-PET/CT has been shown to have an
important role in diagnosis of infected devices [11–14].
Furthermore, FDG-PET/CT contributed to the decision-making
process when device removal was considered. For example, a
patient with LVAD and Streptococcus bovis endocarditis who
underwent FDG-PET/CT had no evidence for LVAD apparatus
infection (Fig. 3). However, a malignant colonic polyp was
demonstrated and subsequently resected and veriﬁed as villous
adenoma. The unnecessary LVAD extraction was prevented
with a complete eradication of the infection and with no further
requirements for interventions over a 1-year follow up. The
role of FDG-PET/CT in this setting has been demonstrated in
the literature, although only in case reports or small case series
[30].
Another important ﬁnding was the signiﬁcant impact of
FDG-PET/CT ﬁndings on therapeutic decisions. In more than
30% of patients the treatment plan was altered according to the
FDG-PET/CT ﬁndings. Especially important were the surgical
procedures that were performed and the unnecessary deviceClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectextraction that was prevented owing to the FDG-PET/CT
ﬁndings. Undoubtedly, FDG-PET/CT can provide considerable
information used for risk stratiﬁcation and in the decision-
making process for treatment strategy planning in selected
cases where the diagnosis of IE is uncertain or when involve-
ment of implantable devices is suspected.
The role of FDG-PET/CT in the diagnosis of valvular endo-
carditis has been suggested by several small studies and sporadic
case reports; however, with some controversy [15–21]. This
controversy most probably derives from the lack of a stan-
dardized protocol for myocardium imaging with FDG-PET/CT.
Several authors [31,32] suggested a protocol where patients
were instructed to maintain a very low carbohydrate and fat-
rich diet a day before the imaging. The optimal duration of
fasting to reduce myocardial FDG uptake is yet to be deter-
mined. Our study demonstrated disappointing results regarding
the ability of FDG-PET/CT to identify intra-cardiac infected
structures. Since our study was designed to investigate mainly
the extra-cardiac complications, we used the standard protocol
for whole body FDG-PET/CT, which could theoretically explain
the low cardiac detection rate. We suggest that the role of
FDG-PET/CT in the diagnosis of valvular endocarditis should be
further evaluated with an established standardized protocol.
As mentioned, few data exist on the role of whole body
FDG-PET/CT in the diagnosis of ECC comprising very small
studies with differing study designs. Van Riet et al. [22] evalu-
ated 24 patients with deﬁnite endocarditis and demonstrated an
ECC rate of 44% using FDG-PET/CT. Our study, which was
larger, demonstrated a slightly higher detection rate. The study
of Bonﬁglioli et al. [23] included 71 patients with suspected
endocarditis with an ECC detection rate of only 24%. Recently,
Bertagna et al. [24] investigated the role of FDG-PET/CT in
diagnosis of prosthetic valve endocarditis in 72 patients with
suspected endocarditis. ECC were detected in only eight pa-
tients. The higher detection rate in our study could be
explained by the well-deﬁned population with a deﬁnite diag-
nosis of IE and possible discrepancies in deﬁnitions of extra-
cardiac complications between the studies.LimitationsOur study has several limitations: this is a single centre study
with a relatively small population sample. We did not perform a
systematic comparison of the FDG-PET/CT ﬁndings to other
diagnostic modalities. One of our intentions was to investigate
the impact of FDG-PET/CT ﬁndings on patient management, so
we avoided any interference with the patient evaluation and
treatment plan. We aimed to perform our study as close as
possible to the accepted common practice in IE. For ethicalious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 69–76
CMI Orvin et al. FDG-PET/CT in detection of ECC 75reasons, we were limited to a single FDG-PET/CT examination
and we could not postpone the initiation of antibiotic treatment
until after the examination was performed. Consequently, it is
possible that we have underestimated the true incidence of
ECC. Furthermore, we could not perform additional standard
imaging to compare our FDG-PET/CT results to the reference
standard because of the substantial extra radiation exposure.ConclusionsFDG-PET/CT was useful for detection of embolic and meta-
static infections in IE patients. The potential beneﬁt for FDG-
PET/CT imaging in the evaluation of IE derives from its ability
to provide simultaneous important data regarding embolization
and metastasis of infection to distant organs, possible portal of
entry of the infection and evidence for foreign body involve-
ment. All of this essential information has signiﬁcant impact on
diagnosis and treatment planning. Our study results reinforce
the results of previous studies, suggesting a role for FDG-PET/
CT in the evaluation of patients with IE. The potential role of
FDG-PET/CT in the evaluation of patients with IE should be
further evaluated in larger cohort studies.Transparency DeclarationThe authors declare that they have no conﬂicts of interest.References[1] Jaffe WM, Morgan DE, Pearlman AS, Otto CM. Infective endocarditis,
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